Journal of Isfahan Medical School

Journal of Isfahan Medical School

Development of Guidelines for Diagnostic Procedures in Identifying Latent Liver Failure and Asymptomatic Gastrointestinal Malignancies before Bariatric Surgery

Document Type : Original Article(s)

Authors
Elham Tabesh 1
Masoud Sayadi Shahraki 2
Maryam Soheilipour 3
Abbas Ahmadifar 4
Peiman Adibi 5
1 Associate Professor of Gastroenterology and Hepatology,Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences
2 Associate Professor of Laparoscopic Surgery, Department of Surgery, School of Medicine, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
3 Associate Professor of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences
4 Department of Internal Medicine, School of Medicine, Integrative Functional Gastroenterology Research, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
5 Professor of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Integrative Functional Gastroenterology Research Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
10.48305/jims.v43.i846.1902
Abstract
Background: Recent advances in bariatric surgery have necessitated the need for careful preoperative assessment of comorbidities. Occult liver failure and gastrointestinal malignancies can cause serious complications in this group of patients. The aim of this study was to investigate and obtain diagnostic guidelines for the identification, diagnosis, and management of asymptomatic occult liver failure and gastrointestinal malignancies in patients who are candidates for bariatric surgery.
Methods: This study was conducted qualitatively and by collecting the opinions of experts in the field of diagnosis and treatment of gastrointestinal and liver diseases through telephone and face-to-face interviews. Experts active in this field were identified and their opinions on the diagnosis and management of diseases were collected. The data were analyzed to identify patterns and extract key points.
Findings: The findings showed that most experts emphasize the need for comprehensive tests, including liver tests and imaging scans, before surgery. Also, the need for specific protocols in the identification of gastrointestinal malignancies and for patients with a history of inflammatory bowel disease was identified. Finally, a localized guideline for the diagnosis and management of these conditions was proposed.
Conclusion: Developing appropriate guidelines for the identification of latent liver failure and gastrointestinal malignancies in patients undergoing bariatric surgery can help reduce surgical complications and improve patient outcomes. It is recommended that specialists and medical centers pay attention to this guideline and be diligent in implementing it in order to improve the quality of services.

Highlights

Masoud Sayadi Shahraki: Google Scholar

Peyman Adibi : Google Scholar 

Keywords
Latent liver failure
asymptomatic gastrointestinal malignancy
bariatric surgery
clinical guideline
Subjects
1.     Antipass A, Austin A, Awad S, Hughes D, Idris I. Evaluation of liver function tests and risk score assessment to screen patients for significant liver disease prior to bariatric and metabolic surgery. Obes Surg 2020; 30(7): 2840-3.
2.     Varbanova M, Maggard B, Lenhardt R. Preoperative preparation and premedication of bariatric surgical patient. Saudi J Anaesth 2022; 16(3): 287-98.
3.     Zhao B, Zhang J, Zhang J, Zou S, Luo R, Xu H, et al. The impact of preoperative underweight status on postoperative complication and survival outcome of gastric cancer patients: a systematic review and meta-analysis. Nutr Cancer 2018; 70(8): 1254-63.
4.     Shin CI, Kim SH. Normal and abnormal postoperative imaging findings after gastric oncologic and bariatric surgery. Korean J Radiol 2020; 21(7): 793-811.
5.     Elnahas A, Nguyen GC, Okrainec A, Quereshy F, Jackson TD. The effect of underlying liver disease on short-term outcomes following bariatric surgery. Surg Endosc 2014; 28(9): 2708-12.
6.     Benaiges D, Goday A, Pedro-Botet J, Más A, Chillarón JJ, Flores-Le Roux JA. Bariatric surgery: to whom and when? Minerva Endocrinol 2015 ;40(2):119-28.
7.     Doulberis M, Srivastava S, Polyzos SA, Kountouras J, Papaefthymiou A, Klukowska-Rötzler J, et al. Active helicobacter pylori infection is independently associated with nonalcoholic steatohepatitis in morbidly obese patients. J Clin Med 2020; 9(4): 933.
8.     Emile SH. Should We Test for and Eradicate Helicobacter pylori Before Bariatric Surgery? Obes Surg 2021; 31(4): 1841-2.
9.     Geerts A, Darius T, Chapelle T, et al. The multicenter Belgian survey on liver -transplantation for hepatocellular failure after bariatric surgery. Transplant Proc 2010; 42(10): 4395-8.
10.  Lefere S, Hoorens A, Raevens S, Troisi R, Verhelst X, van Vlierberghe H, et al. Refractory subacute steatohepatitis after biliopancreatic diversion. Hepatology 2017; 66(1): 289-91.
11.  Cazzo E, Pareja JC, Chaim EA. Liver failure following biliopancreatic diversions: a narrative review. Sao Paulo Med J 2017; 135(1): 66-70.
12.  Tao W, Santoni G, von Euler-Chelpin M, Ljung R, Lynge E, Pukkala E, et al. Cancer risk after bariatric surgery in a cohort study from the five nordic countries. Obes Surg 2020; 30(10): 3761-7.
13.  Tao W, Artama M, von Euler-Chelpin M, Hull M, Ljung R, Lynge E, et al. Colon and rectal cancer risk after bariatric surgery in a multicountry Nordic cohort study. Int J Cancer 2020; 147(3): 728-35.
14.  Heimgartner B, Herzig M, Borbély Y, Kröll D, Nett P, Tutuian R. Symptoms, endoscopic findings and reflux monitoring results in candidates for bariatric surgery. Dig Liver Dis 2017; 49: 750-6.
15.  Martín-Pérez J, Arteaga-González I, Martín-Malagón A, Díaz-Luis H, Casanova-Trujillo C, Carrillo-Pallarés AA. Frequency of abnormal esophageal acid exposure in patients eligible for bariatric surgery. Surg Obes Relat Dis 2014; 10(6): 1176-80.
16.  D'Silva M, Bhasker AG, Kantharia NS, Lakdawala M. High-percentage pathological findings in obese patients suggest that sophagogastroduodenoscopy should be made mandatory prior to bariatric surgery. Obes Surg 2018; 28(9): 2753-9
17.  Hansdotter I, Björ O, Andreasson A, Agreus L, Hellström P, Forsberg A, Talley NJ, Vieth M, Wallner B. Hill classification is superior to the axial length of a hiatal hernia for assessment of the mechanical anti-reflux barrier at the gastroesophageal junction. Endosc Int Open 2016; 4(3): E311-7.
18.  Angulo P, Lindor KD. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346(16): 1221-31.
19.  Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014; 370(14): 1287-97.
20.  Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70(1): 7-30.
21.  Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K,Rinella M, et al. Clinical practice guidelines on the diagnosis and management of nonalcoholic fatty liver disease. Hepatology 2018; 67(1): 328-57.
22.  Wangchuk P, Yeshi K, Loukas A. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci 2024; 45(10): 892-903.
 
Journal of Isfahan Medical School
Volume 43, Issue 846
2nd Week, March
March and April 2026
Pages 1902-1912

  • Receive Date 01 December 2024
  • Accept Date 25 August 2025